Vous êtes ici : Accueil / Valorisation / Publications / 2020

Infos pratiques

Organigramme
Contacts
  • Directeur :

        Pr Eric DELAPORTE

  • Directeur Adjoint :

        Bernard TAVERNE

Accès à la Délégation Régionale IRD-Occitanie (Montpellier)

2020

Tram J., Le Baccon-Sollier P., Bolloré K., Ducos J., Mondain A.-M., Pastor P., Pageaux G.-P., Makinson A., Van de Perre P., et Tuaillon E.,
RNA testing for the diagnosis of acute hepatitis A during the 2017 outbreak in France,
J. Viral Hepat., janv. 2020. doi: 10.1111/jvh.13255.

Barraud O., Robert A., Laval L., Ruimy R., Morquin D., Boyer L., et Lamy B.,
It takes two to tango: two Aeromonas isolates combine virulence and multidrug resistance in flap infection following leech therapy,
Clin. Microbiol. Infect., janv. 2020. doi: 10.1016/j.cmi.2019.12.021.

Liégeois F., Boyer S., Eymard-Duvernay S., Carrieri P., Kouanfack C., Domyeum J., Maradan G., Ducos J., Mpoudi-Ngolé E., Spire B., Delaporte E., Kuaban C., Vidal L., Laurent C., et EVOLCAM study group,
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM),
BMC Infect. Dis., vol. 20, no 1, p. 49, janv. 2020. doi: 10.1186/s12879-020-4784-7.

Poizot-Martin I., Obry-Roguet V., Duvivier C., Lions C., Huleux T., Jacomet C., Ferry T., Cheret A., Allavena C., Bani-Sadr F., Palich R., Cabié A., Fresard A., Pugliese P., Delobel P., Lamaury I., Hustache-Mathieu L., Brégigeon S., Makinson A., Rey D., et Dat’AIDS study group,
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015,
J Eur Acad Dermatol Venereol, janv. 2020. doi: 10.1111/jdv.16204.

Navarro M., Camprubí D., Requena-Méndez A., Buonfrate D., Giorli G., Kamgno J., Gardon J., Boussinesq M., Muñoz J., et Krolewiecki A.,
Safety of high-dose ivermectin: a systematic review and meta-analysis,
J. Antimicrob. Chemother., janv. 2020. doi: 10.1093/jac/dkz524.

Yakhelef N., Audibert M., Ferlazzo G., Sitienei J., Wanjala S., Varaine F., Bonnet M., et Huerga H.,
Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis,
PLoS ONE, vol. 15, no 1, p. e0227138, 2020. doi: 10.1371/journal.pone.0227138.

Atwine D., Baudin E., Gelé T., Muyindike W., Mworozi K., Kyohairwe R., Kananura K., Orikiriza P., Nyehangane D., K T Nanjebe D., Furlan V., Verstuyft C., Barrail-Tran A., Taburet A.-M., Bonnet M., et ANRS 12292 Rifavirenz study group,
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial,
J. Antimicrob. Chemother., janv. 2020. doi: 10.1093/jac/dkz557.

Ayouba A. et Peeters M.,
Reply to Zhang et al,
J. Infect. Dis., févr. 2020. doi: 10.1093/infdis/jiaa041.

Bonnet M.,
Xpert MTB/RIF Ultra: what is the real impact?,
Lancet Respir Med, févr. 2020. doi: 10.1016/S2213-2600(20)30050-3.

Tuaillon E., Kania D., Pisoni A., Bollore K., Taieb F., Ontsira Ngoyi E. N., Schaub R., Plantier J.-C., Makinson A., et Van de Perre P.,
Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C,
Front Microbiol, vol. 11, p. 373, 2020. doi: 10.3389/fmicb.2020.00373.

Coulaud P.-J., Sagaon-Teyssier L., Mimi M., M’madi Mrenda B., Maradan G., Mora M., Bourrelly M., Keita B. D., Keita A. A., Anoma C., Babo Yoro S.-A., Dah T. T. E., Coulibaly C., Mensah E., Agbomadji S., Bernier A., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Combined Sexual Behavioral Profiles in HIV-Seronegative Men Who have Sex with Men in West Africa (CohMSM ANRS 12324-Expertise France),
Arch Sex Behav, vol. 49, no 1, p. 331‑345, 2020. doi: 10.1007/s10508-019-01513-z.

Martinez L., Cords O., Horsburgh C. R., Andrews J. R., et Pediatric TB Contact Studies Consortium,
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis,
Lancet, vol. 395, no 10228, p. 973‑984, 21 2020. doi: 10.1016/S0140-6736(20)30166-5.

Lienhardt C., Nunn A., Chaisson R., Vernon A. A., Zignol M., Nahid P., Delaporte E., et Kasaeva T.,
Advances in clinical trial design: Weaving tomorrow’s TB treatments,
PLoS Med., vol. 17, no 2, p. e1003059, févr. 2020. doi: 10.1371/journal.pmed.1003059.

Coulaud P.-J., Sagaon-Teyssier L., Mimi M., Maradan G., Mora M., Bourrelly M., Dembélé Keita B., Keita A. A., Anoma C., Yoro S.-A. B., Dah E. T. T., Coulibaly C., Mensah E., Agbomadji S., Palvadeau P., Bernier A., Rojas Castro D., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Changes in risky sexual behaviours among West African MSM enrolled in a quarterly HIV testing and counselling prevention programme (CohMSM ANRS 12324 - Expertise France),
Sex Transm Infect, vol. 96, no 2, p. 115‑120, mars 2020. doi: 10.1136/sextrans-2018-053892.

For the 2-Lady Group, Boyer S., Nishimwe M. L., Sagaon-Teyssier L., March L., Koulla-Shiro S., Bousmah M.-Q., Toby R., Mpoudi-Etame M. P., Ngom Gueye N. F., Sawadogo A., Kouanfack C., Ciaffi L., Spire B., et Delaporte E.,
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa,
PharmacoEconomics Open, vol. 4, no 1, p. 45‑60, mars 2020. doi: 10.1007/s41669-019-0157-9.

Sams K., Desclaux A., et Sow S.,
They’ll inject you and you’ll die : from medication non-compliance to acceptance in Guinea’s Ebola treatment units,
Anthropol Med, vol. 27, no 1, p. 1‑16, mars 2020. doi: 10.1080/13648470.2019.1615749.

Frange P., Tubiana R., Sibiude J., Canestri A., Arvieux C., Brunet-Cartier C., Cotte L., Reynes J., Mandelbrot L., Warszawski J., Le Chenadec J., et ANRS EPF CO1/CO11 Study Group,
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?,
J. Antimicrob. Chemother., mars 2020. doi: 10.1093/jac/dkaa017.

Jacquet J.-M., Donnadieu-Rigole H., Peries M., Makinson A., Nagot N., Reynes J., Peyriere H., et MesConsos study group name,
Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study,
HIV Med., vol. 20, no 4, p. 286‑290, 2019. doi: 10.1111/hiv.12709.

Etard J.-F., Vanhems P., Atlani-Duault L., et Ecochard R.,
Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020,
Euro Surveill., vol. 25, no 15, 2020. doi: 10.2807/1560-7917.ES.2020.25.15.2000448.

De Baetselier I., Vuylsteke B., Yaya I., Dagnra A., Diandé S., Mensah E., Dah E., Anoma C., Koné A., Fayé-Ketté H., Yeo A., Keita B. D., Laurent C., Crucitti T., et CohMSM-PrEP pooling study group,
To pool or not to pool samples for Sexually Transmitted Infections detection in Men who have Sex with Men? An evaluation of a new pooling method using the GeneXpert instrument in West-Africa,
Sex Transm Dis, avr. 2020. doi: 10.1097/OLQ.0000000000001191.